Federal Territory of Kuala Lumpur, Malaysia, February 28, 2025 -- SurgeGraph, an AI writing tool designed to help users grow ...

Federal Territory of Kuala Lumpur, Malaysia, February 28, 2025 -- SurgeGraph, an AI writing tool focused on helping users ...

The MCU has always delivered great spectacles. That was true in Captain America: Brave New World. But plenty of meaningless ...

Prothena (NASDAQ:PRTA – Free Report) had its target price upped by Piper Sandler from $94.00 to $110.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

Sports betting platform SeuBet has just announced the opening of new positions to strengthen its team and keep up with the ...

SurgeGraph, an AI writing tool focused on helping users grow their traffic through SEO-optimized long-form content, has ...

Sen. Roger Marshall (R-Kan.) moved Wednesday to prohibit federal grants going toward all “dangerous” gain-of-function ...

Chinese smartphone maker Tecno on Friday said to launch Spark Slim, world’s thinnest phone with a 5200 mAh battery at Mobile ...

Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.